Among other members of this exporter family representing downstream targets of MYCN, ABCG2 is unique in its strong association with a cancer stem cell-enriched tumor phenotype exhibiting inherently high resistance to chemotherapeutic agents [8]. Here, MYCN is linked to neoplasm.